FDA Approves HPV Vaccine For Men And Women Aged 27 To 45
The New York Times (10/5, Grady, Hoffman) reported that the Food and Drug Administration has approved the HPV vaccine “for men and women from 27 to 45-years-old.” The article noted that the vaccine “had been previously approved for minors and people up to age 26.” The HPV vaccine “works against the human papillomavirus, HPV, which can also cause genital warts and cancers” including “tumors affecting part of the throat – called oropharyngeal cancers” which are on the rise.
CNN (10/5, Lamotte) reported that Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said, “HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing.”
The Washington Post (10/5, McGinley) reported that the approval “represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” said Dr. Marks.
Dentists can refer patients to MouthHealthy.org for information on oral cancer and HPV and oropharyngeal cancer, and JADA For the Patient includes the article Oral cancer: What to do if something unusual shows up. The ADA also offers the brochure “Get The Facts About Mouth and Throat Cancer.”